Building the data tool that should have already been built.

It's 2023 and it's still hard for you to find answers to basic questions about your work. The reality is that most people lack even basic transparency into their day-to-day work. While not everyone needs data every day to do their jobs - our team has seen first-hand how impactful data in the delivery of cancer care can be. The number of jobs and industries where data can play a critical role is growing every year: from sales and marketing teams to healthcare organizations and fintech companies. There are far more analytical people hidden away in modern organizations that are good at asking key questions than there are answers for these people. Part of this problem should be solved with data teams, culture and training. But there is also a huge opportunity to make better tools for curious and analytical humans.

Glean treats data inside modern organizations as a product problem - a problem that benefits from rethinking the user experience and technology used to visualize and interact with data. We believe that technology can play a part in getting more organizations to get value out of their data, even organizations that don't have large data teams. Glean looks to scale with a team so that it's one of the first tools teams use to share data, but also build in advanced workflows like continuous integration and version control.

Glean has raised 7 million dollars in seed financing led by Ilya Sukhar at Matrix Parners. We also have participation from great product angels like: Elad Gil, Dylan Field (Figma), Shana Fisher, Scott Belsky (Behance), Cristina Cordova (fmr Stripe, Notion) and data angels like DJ Patil (fmr US CIO) and Anthony Goldbloom (Kaggle). The Flatiron Health founding team also substantially invested in Glean at the earliest stages: Gil Shklarski, Nat Turner and Zach Weinberg.